prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - (αιμοσυγκολλητίνη και νευραμινιδάση) του στελέχους Α / Βιετνάμ / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - Εμβόλια - Ενεργός ανοσοποίηση έναντι του υποτύπου h5n1 του ιού της γρίπης Α. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
cataflam 1.5% oral drops solution
novartis pharmaceuticals uk ltd, surrey (0000007817) frimley business park, frimley camberley, surrey, gu16 7sr - diclofenac sodium - oral drops solution - 1.5% - diclofenac sodium (0015307796) 15mg - diclofenac
lescol 20mg capsule,hard
novartis pharmaceuticals uk ltd, surrey - Η ΦΛΟΥΒΑΣΤΑΤΊΝΗ ΝΑΤΡΊΟΥ - capsule,hard - 20mg - 8000000140 - fluvastatin sodium - 20 mg - fluvastatin
lescol 40mg capsule,hard
novartis pharmaceuticals uk ltd, surrey - Η ΦΛΟΥΒΑΣΤΑΤΊΝΗ ΝΑΤΡΊΟΥ - capsule,hard - 40mg - 8000000140 - fluvastatin sodium - 40 mg - fluvastatin
tears naturale ii
novartis pharmaceuticals uk ltd, surrey - ΥΠΡΟΜΕΛΛΌΖΗ, ΔΕΞΤΡΆΝΗ 70 - eye drops - 0008063829 - hypromellose - 3 mg; 8000007309 - dextran 70 - 1 mg - artificial tears and other indifferent prep.
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformin hydrochloride - Σακχαρώδης διαβήτης τύπου 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 και 5. 1 για διαθέσιμα δεδομένα σχετικά με διαφορετικούς συνδυασμούς).
tekturna
novartis europharm ltd. - αλισκιρένη - Υπέρταση - Παράγοντες που δρουν στο σύστημα ρενίνης-αγγειοτενσίνης - Θεραπεία της ιδιοπαθούς υπέρτασης.
timolol/novartis 0.25% w/v ey.dro.sol
novartis (hellas) a.e.b.e. - timolol - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - 0.25% w/v - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
timolol/novartis 0.5% w/v ey.dro.sol
novartis (hellas) a.e.b.e. - timolol - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - 0.5% w/v - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
lamisil continuous spray 1% spr.sol
novartis (hellas) a.e.b.e. - terbinafine - ΔΕΡΜΑΤΙΚΟ ΕΚΝΕΦΩΜΑ, ΔΙΑΛΥΜΑ - 1% - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ